Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

GALT Galectin Therapeutics Inc

1,20

-0,03 (-2,44%)

Vor Marktöffnung

Zuletzt aktualisiert: 15:00:34

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Galectin Therapeutics Charts.

Galectin Therapeutics (NASDAQ:GALT)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Galectin Therapeutics Charts.

News Galectin Therapeutics Inc

Form 8-K - Current report
Dienstag 28 Januar 2025 (1 Tag vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 27 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 23 Januar 2025 (6 Tage vor) • Edgar (US Regulatory)

Weitere Galectin Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen